The WTA’s new genetic sex testing policy has quickly become one of the most heavily discussed sports governance topics of the year.
WTA stars, including World No. 3 Jessica Pegula, have begun addressing the policy’s details, which seek to establish standardized genetic eligibility criteria across all professional women’s tennis tournaments.
While the WTA states that the policy ensures fair competition, players and coaches have raised critical questions regarding the implementation timeline, medical privacy, and how it aligns with other international sports federations.
WTA Eligibility Policy Portal
Interact with the tool below to view the key pillars of the new WTA Genetic Sex Testing policy and check the compliance thresholds:
📋 WTA Genetic Eligibility Portal
Policy Rule: Chromosomal Screenings
Standardized genetic screening checks to verify chromosomal eligibility profiles prior to tour registration.
Players Raise Privacy Concerns
While many players support standardizing rules across all tournaments, privacy is the biggest point of contention. Several top athletes have pointed out that genetic testing details are highly sensitive medical files.
WTA representatives have responded by confirming that all genetic screens are managed by an independent medical panel, ensuring that player names and files remain completely anonymous to the public and the media.
Alignment with the US Open and ITF
The WTA’s policy update has been coordinated in partnership with the International Tennis Federation (ITF) and individual Grand Slam boards (such as the USTA). This ensures that eligibility rules are identical, preventing situations where a player is eligible for standard WTA tournaments but banned from Grand Slams like the U.S. Open.